DEFA5 and Cowden disease: In 1 of the few clinical trials available, administration of Bifidobacterium infantis decreased Paneth cells and expression of α-defensin-5 in duodenal biopsies of patients with active CD,41 an effect that was associated with symptom improvement but did not modify abnormal intestinal permeability.42